<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01255878</url>
  </required_header>
  <id_info>
    <org_study_id>87284</org_study_id>
    <nct_id>NCT01255878</nct_id>
  </id_info>
  <brief_title>Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism</brief_title>
  <official_title>The Efficacy of Gabapentine and Splint Therapy in Bruxers: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mashhad University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mashhad University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      Sleep bruxism (SB) is defined as a &quot;stereotyped movement disorder characterized by grinding
      or clenching of the teeth during sleep&quot; usually associated with sleep arousal. It might lead
      to abrasive tooth wear, hypermobility of teeth, tooth hypersensitivity, hypertrophy of the
      masticatory muscles and pain in the masticatory muscles.

      Diagnostic procedures include clinical evaluation, ambulatory monitoring sleep laboratory
      investigations and others. The clinical approach comprises the patient's history, orofacial
      examination, and tooth wear classification.

      There is no specific treatment for bruxism. Management of SB comprises psychological,
      orodental and pharmacological strategies.Orodental therapies, including soft vinyl mouth
      guards or stabilization bite splints, probably function more like protectors of the orofacial
      structures rather than actually diminishing bruxism.Drug treatment of sleep bruxism is
      controversial since different treatment strategies have resulted in suppression or
      exacerbation of this condition.

      Based on the current data, central primary efferents are the major drivers of bruxism.
      Therefore centrally acting agents such as antiepileptic drugs which also affect the sleep
      structure, might be effective on SB.

      In a case report of bruxism, anxiety and tremor, the authors suggested that anti-convulsant
      Gabapentine may be a useful treatment for patients with antidepressant-induced bruxism.
      However in the absence of definitive evidence, the appropiate treatment of SB is still a
      matter of debate.

      The objective of the present study was to compare the treatment efficacy of occlusal
      stabilization splint and Gabapentine on SB, using polysomnographically determined outcome
      measures for the quantification of sleep bruxism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Sleep Bruxism</condition>
  <arm_group>
    <arm_group_label>stabilization splint</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gabapentine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>occlusal stabilization splint</intervention_name>
    <arm_group_label>stabilization splint</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentine</intervention_name>
    <description>100 mg(1 capsule)three times per day for two months</description>
    <arm_group_label>Gabapentine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical and polysomnographic criteria of sleep bruxism according to the international
             classification of sleep disorders

        Exclusion Criteria:

          -  Loss of more than two teeth and having removable prosthesis

          -  Presence of a major malocclusion

          -  Using any medication with a known influence on sleep structure or sleep bruxism

          -  Being diagnosed with psychological or neurotic disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Azamsadat Madani, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mashhad University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadia Hasanzadeh, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mashhad University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hasan Azangoo, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mashhad University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ebrahim Abdollahian, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mashhad University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mashhad University Of Medical Sciences</name>
      <address>
        <city>Mashhad</city>
        <state>Khorasan Razavi</state>
        <zip>91735</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Brown ES, Hong SC. Antidepressant-induced bruxism successfully treated with gabapentin. J Am Dent Assoc. 1999 Oct;130(10):1467-9.</citation>
    <PMID>10570590</PMID>
  </reference>
  <reference>
    <citation>Dubé C, Rompré PH, Manzini C, Guitard F, de Grandmont P, Lavigne GJ. Quantitative polygraphic controlled study on efficacy and safety of oral splint devices in tooth-grinding subjects. J Dent Res. 2004 May;83(5):398-403.</citation>
    <PMID>15111632</PMID>
  </reference>
  <reference>
    <citation>Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, Mascha E, Dinner D, Morris HH. Gabapentin increases slow-wave sleep in normal adults. Epilepsia. 2002 Dec;43(12):1493-7.</citation>
    <PMID>12460250</PMID>
  </reference>
  <reference>
    <citation>Kast RE. Tiagabine may reduce bruxism and associated temporomandibular joint pain. Anesth Prog. 2005 Fall;52(3):102-4.</citation>
    <PMID>16252740</PMID>
  </reference>
  <reference>
    <citation>Kato T, Thie NM, Huynh N, Miyawaki S, Lavigne GJ. Topical review: sleep bruxism and the role of peripheral sensory influences. J Orofac Pain. 2003 Summer;17(3):191-213. Review.</citation>
    <PMID>14520766</PMID>
  </reference>
  <reference>
    <citation>Lavigne GJ, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil. 2008 Jul;35(7):476-94. doi: 10.1111/j.1365-2842.2008.01881.x. Review.</citation>
    <PMID>18557915</PMID>
  </reference>
  <reference>
    <citation>Lobbezoo F, Naeije M. Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil. 2001 Dec;28(12):1085-91. Review.</citation>
    <PMID>11874505</PMID>
  </reference>
  <reference>
    <citation>Placidi F, Mattia D, Romigi A, Bassetti MA, Spanedda F, Marciani MG. Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels. Clin Neurophysiol. 2000 Sep;111(9):1637-42.</citation>
    <PMID>10964076</PMID>
  </reference>
  <reference>
    <citation>Saletu A, Parapatics S, Anderer P, Matejka M, Saletu B. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo. Eur Arch Psychiatry Clin Neurosci. 2010 Mar;260(2):163-74. doi: 10.1007/s00406-009-0034-0. Epub 2009 Jul 15.</citation>
    <PMID>19603241</PMID>
  </reference>
  <reference>
    <citation>Stapelmann H, Türp JC. The NTI-tss device for the therapy of bruxism, temporomandibular disorders, and headache - where do we stand? A qualitative systematic review of the literature. BMC Oral Health. 2008 Jul 29;8:22. doi: 10.1186/1472-6831-8-22.</citation>
    <PMID>18662411</PMID>
  </reference>
  <reference>
    <citation>Lavigne GJ, Rompré PH, Montplaisir JY. Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study. J Dent Res. 1996 Jan;75(1):546-52.</citation>
    <PMID>8655758</PMID>
  </reference>
  <reference>
    <citation>Lavigne GJ, Rompré PH, Poirier G, Huard H, Kato T, Montplaisir JY. Rhythmic masticatory muscle activity during sleep in humans. J Dent Res. 2001 Feb;80(2):443-8.</citation>
    <PMID>11332529</PMID>
  </reference>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2010</study_first_submitted>
  <study_first_submitted_qc>December 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2010</study_first_posted>
  <last_update_submitted>December 7, 2010</last_update_submitted>
  <last_update_submitted_qc>December 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Mashhad University of Medical Sciences</name_title>
    <organization>Mashhad University of Medical Sciences</organization>
  </responsible_party>
  <keyword>Sleep bruxism</keyword>
  <keyword>Gabapentine</keyword>
  <keyword>Occlusal splint</keyword>
  <keyword>Polysomnography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bruxism</mesh_term>
    <mesh_term>Sleep Bruxism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salicylic Acid</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

